⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL16968731 | 0.97 | — | — | |
| SCHEMBL872311 | 0.86 | — | — | |
| SCHEMBL21847348 | 0.76 | TSHR (0.31) | — | |
| Ammonia Solution, Strong SCHEMBL27888322 | 0.71 | — | — | |
| SCHEMBL669682 | 0.67 | — | — | |
| SCHEMBL21858419 | 0.67 | — | — | |
| SCHEMBL5831420 | 0.67 | — | — | |
| SCHEMBL16481813 | 0.67 | — | — | |
| SCHEMBL873956 | 0.67 | — | — | |
| SCHEMBL217249 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1807104-A1 | BOTULINUM TOXIN THERAPY OF HEART RHYTHM DISORDERS | Ipsen Limited (GB) | 2007-07-18 | — | — | EP | claimed |
| WO-2006046065-A1 | BOTULINUM TOXIN THERAPY OF HEART RHYTHM DISORDERS | IPSEN LIMITED (GB) | 2006-05-04 | — | — | WO | claimed |
| EP-4724518-A1 | RING-OPENING POLYMERISATION METHOD | Elkem Silicones France SAS (FR) | 2026-04-15 | — | — | EP | disclosed |
| WO-2024252074-A1 | RING-OPENING POLYMERISATION METHOD | ELKEM SILICONES FRANCE SAS (FR) | 2024-12-12 | — | — | WO | disclosed |
| US-20220213294-A1 | UNSATURATED POLYESTER RESIN SYSTEM FOR CURED IN-PLACE PIPING | INTERPLASTIC CORPORATION | 2022-07-07 | — | — | US | disclosed |
| US-11180632-B2 | Unsaturated polyester resin system for cured in-place piping | INTERPLASTIC CORPORATION (US) | 2021-11-23 | — | — | US | disclosed |
| US-20200370033-A1 | BIOLOGICAL ASSEMBLY INCLUDING BIOLOGICAL COMPONENT AND SHIELD | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2020-11-26 | — | — | US | disclosed |
| US-20190153196-A1 | UNSATURATED POLYESTER RESIN SYSTEM FOR CURED IN-PLACE PIPING | INTERPLASTIC CORPORATION | 2019-05-23 | — | — | US | disclosed |
| US-10131766-B2 | Unsaturated polyester resin system for cured in-place piping | INTERPLASTIC CORPORATION (US) | 2018-11-20 | — | — | US | disclosed |
| WO-2018200336-A1 | UNSATURATED POLYESTER RESIN SYSTEM FOR CURED IN-PLACE PIPING | INTERPLASTIC CORPORATION (US) | 2018-11-01 | — | — | WO | disclosed |
| US-20180305521-A1 | UNSATURATED POLYESTER RESIN SYSTEM FOR CURED IN-PLACE PIPING | INTERPLASTIC CORPORATION | 2018-10-25 | — | — | US | disclosed |
| US-20070259002-A1 | Botulinum Toxin Therapy of Heart Rhythm Disorders | IPSEN BIOPHARM LIMITED (GB) | 2007-11-08 | — | — | US | disclosed |
| EP-1807104-A1 | BOTULINUM TOXIN THERAPY OF HEART RHYTHM DISORDERS | Ipsen Limited (GB) | 2007-07-18 | — | — | EP | disclosed |
| EP-1773378-A2 | USE OF BOTULINUM TOXIN FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF LITHIASIS OF SALIVARY GLAND, GALL BLADDER, KIDNEY, OR PANCREAS | Ipsen Limited (GB) | 2007-04-18 | — | — | EP | disclosed |
| US-20060263352-A1 | Quantification of botulinum toxin | IPSEN LIMITED (GB) | 2006-11-23 | — | — | US | disclosed |
| WO-2006046065-A1 | BOTULINUM TOXIN THERAPY OF HEART RHYTHM DISORDERS | IPSEN LIMITED (GB) | 2006-05-04 | — | — | WO | disclosed |
| CN-1751238-A | Quantification of botulinum toxin | IPSEN LTD (GB) | 2006-03-22 | — | — | CN | disclosed |
| WO-2006005912-A2 | USE OF BOTULINUM TOXIN FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF LITHIASIS OF SALIVARY GLAND, GALL BLADDER, KIDNEY, OR PANCREAS | IPSEN LIMITED (GB) | 2006-01-19 | — | — | WO | disclosed |
| EP-1597584-A1 | QUANTIFICATION OF BOTULINUM TOXIN | Ipsen Limited (GB) | 2005-11-23 | — | — | EP | disclosed |
| WO-2004074838-A1 | QUANTIFICATION OF BOTULINUM TOXIN | IPSEN LIMITED (GB) | 2004-09-02 | — | — | WO | disclosed |